ence energy regulation.
Two meta-analyses, summarizing data from 24 studies, have reported an increased risk of obesity for individuals with cesarean birth (pooled odds ratio [OR] 1,2 Limitations of earlier studies include small sample size in several studies and lack of adjustment for maternal body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]) and sociocultural factors. Even after adjusting for these measured maternal characteristics, residual confounding is likely. Within-family analysis is one way of controlling for such confounding. Because siblings grow up in similar social, economic, and cultural environments and share the same genetic predisposition to obesity, sibling studies minimize the variation in several of the noncausal factors that could explain why cesarean delivery could appear to be associated with a higher risk of obesity. The main objective of this study was to examine within-family and additional between-family associations of delivery route with BMI z score at 5 years of age in a large cohort of sibling pairs to separate most putative confounding effects from the effects of cesarean delivery.
Methods | We used data from the Linked CENTURY (Collecting Electronic Nutrition Trajectory Data Using Records of Youth) study, a longitudinal clinical database of well-child visits linked to each child's birth certificate. 4 The Linked CENTURY study includes singleton-birth children younger than 18 years who were seen for a well-child visit at Atrius Harvard Vanguard Medical Associates in eastern Massachusetts from 1980 through 2008 and whose data were linked to their Massachusetts birth certificate. We included 16 140 siblings born between 1987 and 2003 and their 8070 mothers. We obtained delivery route, which was the main exposure, from birth certificates. We extracted height and weight data for children at least 5 and less than 6 years of age from electronic health records and calculated BMI as weight in kilograms divided by height in meters squared. This study was approved and informed consent was waived by the Harvard Pilgrim Health Care Institutional Review Board. Our main outcome was age-specific and sex-specific BMI z score at 5 years of age based on Centers for Disease Control and Prevention reference data. 5 We used a single linear mixed model, adjusted for mother's age, parity, and race/ethnicity and for child's age, sex, and birth year, to decompose the total association of cesarean delivery with BMI z score into a withinfamily component and an additional between-family component. 6 The model equation for this is
where Y ij = BMI z score for the ith individual from the jth family, X ij = individual's cesarean delivery status (0 = no and 1 = yes), X i = family average cesarean deliveries (0 = both siblings vaginal delivery, 0.5 = one sibling vaginal delivery and one sibling cesarean, and 1 = both siblings cesarean), v i = family random effect, and e ij = random error; v i and e ij are assumed to be uncorrelated and normally distributed, each with a mean value of 0. The estimated within-family component β w is mostly unconfounded by other factors. We also fit a model that did not decompose the effect of cesarean delivery; this model approximates the possibly confounded results we would have observed without accounting for sibling status. We fit all models using PROC GLIMMIX, SAS, version 9.4 (SAS Institute, Inc).
Results | A total of 3804 of the 16 140 children (23.6%) had nonwhite mothers. A total of 7943 of the 16 140 children (49.2%) were female, 3204 children (19.9%) had cesarean delivery, and the mean (SD) BMI z score at 5 years of age was 0.48 (1.00). Mean BMI z score was 0.45 among siblings who both had vaginal delivery, 0.51 among siblings with 1 cesarean and 1 vaginal delivery, and 0.63 among siblings who both had cesarean delivery ( Table 1 ).
In the covariate-adjusted model, the within-family association of cesarean vs vaginal delivery was 0.04 higher BMI z score at 5 years of age (95% CI, −0.04 to 0.11) and the additional between-family association was 0.13 (95% CI, 0.04 to 0.22) ( Table 2 ). In a model adjusted for the same covariates, but without decomposing the within-family and betweenfamily effects, children with cesarean delivery had 0.13 higher BMI z score (95% CI, 0.08 to 0.17).
Discussion | We found that, within families, cesarean delivery was not associated with higher BMI z score at 5 years of age. This null finding suggests that confounding by unmeasured variables, such as maternal BMI and sociocultural factors, accounts for observed associations between cesarean delivery and BMI z score in some earlier studies. Such confounding is also reflected in the difference between our within-family estimate (0.04) and our additional between-family estimate (0.13).
This study had several limitations. All patients had health insurance; our results may not be generalizable to individuals without insurance. We did not have data on whether the cesarean delivery was an emergency procedure or data on maternal prepregnancy BMI. Maternal BMI, however, differs more between families than across pregnancies, which is another reason to use a sibling-pairs design. Strengths of this study include the large number of sibling pairs and our ability to link clinical data with birth certificates. We did not observe a within-family effect of cesarean delivery. This finding suggests that reported associations between cesarean delivery and childhood obesity may be confounded by unmeasured variables. = BMI z score for the ith individual from the jth family, X ij = individual's cesarean delivery status (0 = no and 1 = yes), X i = family average cesarean delivery (0 = both siblings vaginal delivery, 0.5 = 1 sibling vaginal delivery and 1 sibling cesarean delivery, and 1 = both siblings cesarean delivery), v i = family random effect, and e ij = random error. c Adjusted for mother's age, parity, and race/ethnicity and child's age, sex, and birth year. 
Variability Among Next-Generation Sequencing Panels for Early-Life Epilepsies
Epilepsy genetics is an emerging field with increasing therapeutic implications resulting from genetic findings. 1 Despite an overall enthusiasm for precision medicine in epilepsy and other disciplines, there remains no consensus on the approach to genetic testing. Although the utility of NGS panels are consistently demonstrated, 3,4 to our knowledge, no study has systematically evaluated the variability in genes tested among clinically available NGS panels. We compared the potential diagnostic yield of commercially available NGS epilepsy panels to detect the genetic findings identified in a recently published cohort of early-life epilepsy.
3
Methods | We compared 10 commercially available NGS gene panels across 3 major vendors: Athena Diagnostics, Ambry Genetics, and GeneDx. From each source, we evaluated early-life epilepsy panels (eg, infantile spasms, epileptic encephalopathy, and stat [rapid] panels) and comprehensive epilepsy panels as of January 24, 2018. We used the list of pathogenic genetic variants from the study by Berg et al 3 to evaluate the theoretical yield for each panel. The Boston Children's Hospital Institutional Review Board waived approval of this study as it did not involve human participants.
Results | Epilepsy NGS panels displayed a wide range in genes covered: 10 to 75 genes for early-life epilepsy panels and 87 to 234 genes for comprehensive epilepsy panels. Only the largest comprehensive epilepsy panel encompassed all genes on the smaller panels. All other panels had incomplete overlap in tested genes, including those with similar indications (eg, panels for infantile spasms). We compared the anticipated detection rate for each panel with the genetic findings identified in the study by Berg et al. 3 This analysis reports the yield each panel would have if it were executed today and assuming optimal technical conditions and coverage. Early-life epilepsy panels included 7% to 40% of genes reported in the cohort (Table) . In our analysis, the early-life epilepsy panels would have missed between 41% and 86% of the patients with pathogenic variants in confirmed epilepsy genes. Epilepsy NGS panels often do not include recently identified epilepsy genes or genes associated with a syndrome in which epilepsy is not a core feature. Coverage and detection of exon-level deletions or duplications can vary across panels. Our study underscores the importance of a clinician's diagnostic suspicion to select the appropriate test for the appropriate patient. Despite the limitations, an appropriately chosen NGS panel remains an important step in the diagnostic workup for epilepsy.
This study highlights the variability across NGS panels and leads to the following recommendations for researchers, diagnostic laboratories, and clinicians. Research using NGS panels may not be generalizable, and future research should 
